tirzepatide belgie Weighing benefits, risks of GLP-1 weight-loss drugs Tirzepatide (Month 1) 2.5mg |

Multiple studies have demonstrated that infant exposure through breast milk is clinically insignificant, with no adverse effects reported

However, some patients may experience more serious side effects such as pancreatitis, kidney damage, and severe allergic reactions

Leptin is known to have pro-inflammatory properties

This titration schedule means that maximal therapeutic effects may not be apparent for several months

Keywords: Tirzepatide, Incretin, Twincretin, Type 2 Diabetes, Weight Loss, GLP-1/GIP receptor agonist Introduction/background: role of incretins in diabetes and weight Incretins are endogenous proteins responsible for multiple bodily functions including the moderation of blood glucose and the feelings of satiety [1]